Entero Therapeutics regains Nasdaq annual meeting compliance

GridAI Technologies Corp.

Received Nasdaq letter confirming compliance with Listing Rule 5620(a) after holding Annual Meeting on June 30, 2025.
Matter is now closed; no further action required from Nasdaq.
Company had previously reported the meeting in a Form 8-K filed July 2, 2025.

item 8.01

Source: SEC EDGAR

accession 0001104659-25-066418

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.